Mismatch repair protein deficiency in triple-negative breast carcinomas.

Bayan MaraqaMaxim Al-AshhabHamza ZughaierFareed BarakatMajd KhaderHussein Al MaaitahRuba AlabwehMaher A Sughayer

Published in: The Journal of international medical research (2024)

Approximately 9% of TNBC patients exhibit dMMR. dMMR could be used to predict outcomes and identify patients with TNBC who may benefit from immunotherapy.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
high grade
patient reported outcomes
protein protein
replacement therapy